Tetracycline affects abnormal properties of synthetic PrP peptides and PrP(Sc) in vitro

Journal of Molecular Biology

Volumn 300, Issue 5, 2000, Pages 1309-1322

  Tagliavini, Fabrizio ^a   Forloni, Gianluigi ^b   Colombo, Laura ^b   Rossi, Giacomina ^a   Girola, Laura ^b   Canciani, Barbara ^a   Angeretti, Nadia ^b   Giampaolo, Lidia ^a   Peressini, Elisa ^b   Awan, Tazeen ^a   De Gioia, Luca ^c   Ragg, Enzio ^d   Bugiani, Orso ^a   Salmona, Mario ^b  

^a DEPARTMENT OF NEUROSURGERY   (Italy)

^b MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^c UNIVERSITY OF MILANO BICOCCA   (Italy)

^d UNIVERSITY OF MILAN   (Italy)

Author keywords

Amyloidogenesis; Cell cultures; NMR spectroscopy; PrP peptides; Tetracycline

Indexed keywords

AMYLOID; ISOPROTEIN; PRION PROTEIN; TETRACYCLINE;

ANIMAL CELL; ARTICLE; ASTROCYTOSIS; CREUTZFELDT JAKOB DISEASE; DRUG EFFECT; DRUG MECHANISM; DRUG PROTEIN BINDING; FETUS; HUMAN; NERVE CELL CULTURE; NERVE CELL NECROSIS; NONHUMAN; PRION DISEASE; PRIORITY JOURNAL; PROTEIN SYNTHESIS INHIBITION; RAT;

EID: 0034725536     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmbi.2000.3840     Document Type: Article

References (64)

1. MS-8209, a new amphotericin B derivative, provides enhanced efficacy in delaying hamster scrapie
2. Densitometric quantification of neural viability by computerized image analysis
3. Non-genetic propagation of strain-specific properties of scrapie prion protein
4. Mouse cortical cells lacking cellular PrP survive in culture with a neurotoxic PrP fragment
5. Role of microglia and host prion protein in neurotoxicity of a prion protein fragment
6. Precise targeting of the pathology of the sialoglycoprotein PrP and vacuolar degeneration in mouse scrapie
7. Transmission to mice indicate that 'new variant' CJD is caused by the BSE agent
8. The anti-prion activity of Congo red
9. Potent inhibition of scrapie-associated PrP accumulation by Congo red
10. Sulfated polyanion inhibition of scrapie-associated PrP accumulation in cultured cells
11. Secondary structure analysis of the scrapie-associated protein PrP 27-30 in water by infrared spectroscopy
12. Methods for studying prion protein (PrP) metabolism and the formation of protease-resistant PrP in cell culture and cell-free systems
13. Inhibition of protease-resistant prion protein formation by porphyrins and phtalocyanines
14. Molecular analysis of prion strain variation and the aetiology of new variant CJD
15. PrP(Sc) in scrapie-infected hamster brain is spatially and temporally related to histopathology and infectivity titer
16. Three scrapie prion isolates exhibit different accumulation patterns of the prion protein scrapie isoform
17. Conformational polymorphism of the amyloidogenic and neurotoxic peptide homologous to residues 106-126 of the prion protein
18. Chemoprophylaxis of scrapie in mice
19. Structure of the recombinant full-length hamster prion protein PrP (29-231): The N terminus is highly flexible
20. Dextran sulphate 500 delays and prevents mouse scrapie by impairment of agent replication in spleen
21. Prolongation of scrapie incubation period by an injection of dextran sulphate 500 within the month before or after injection
22. Neurotoxicity of a prion protein fragment
23. A neurotoxic prion protein fragment induces rat astroglial proliferation and hypertrophy
24. Neuroprotective effect of somatostatin on non-apoptotic NMDA-induced neuronal death: Role of cGMP
25. Epidemiological determinants of the pattern and magnitude of the vCJD epidemic in Great Britain
26. Endogenous proteolytic cleavage of normal and disease-associated isoforms of the human prion protein in neural and non-neural tissues
27. Congo red prolongs the incubation period in scrapie-infected hamsters
28. Antimicrobial agents
29. Mouse polyclonal and monoclonal antibody to scrapie-associated fibril proteins
30. The antiviral compound HPA-23 can prevent scrapie when administered at the time of infection
31. Suppression of scrapie infection in mice by heteropolyanion 23, dextran sulfate, and some other polyanions
32. Cell-free formation of protease-resistant prion protein
33. Interaction of the anthracycline 4'-iodo-4'-deoxydoxorubicin with amyloid fibrils: Inhibition of amyloidogenesis
34. Cytoprotective effects of NMDA receptor antagonists on prion protein (Prion(Sc))-induced toxicity in rat cortical cell cultures
35. The kinetics of the NOE
36. Conversion of α-helices into β-sheets features in the formation of the scrapie prion proteins
37. Molecular basis of phenotypic variability in sporadic Creutzfeldt-Jacob disease
38. Typing prion isoforms
39. Microglial cells respond to amyloidogenic PrP peptides by the production of inflammatory cytokines
40. Amphotericin B delays the incubation period of scrapie in intracerebrally inoculated hamsters
41. Porphyrin and phthalocyanine antiscrapie compounds
42. Scrapie prions aggregate to form amyloid-like birefringent rods
43. Molecular biology of prion diseases
44. Prion protein biology
45. NMR structure of the mouse prion protein domain PrP (121-231)
46. NMR characterization of the full-length recombinant murine prion protein, mPrP (23-231)
47. Epitope mapping of the Syrian hamster prion protein utilizing chimeric and mutant genes in a vaccinia virus expression system
48. Conformational transitions, dissociation and unfolding of scrapie amyloid (prion) protein
49. Molecular determinants of the physicochemical properties of a critical prion protein region comprising residues 106-126
50. Antimicrobial agents
51. Molecular characteristics of a protease-resistant, amyloidogenic and neurotoxic peptide homologous to residues 106-126 of the prion protein
52. Reversion of prion protein conformational changes by synthetic β-sheet breaker peptides
53. Elimination of prions by branched polyamines and implications for therapeutics
54. Amyloid protein of Gerstmann-Straussler-Scheinker disease (Indiana kindred) is an 11 kd fragment of prion protein with an N-terminal glycine at codon 58
55. Synthetic peptides homologous to prion protein residues 106-147 form amyloid-like fibrils in vitro
56. Amyloid fibrils in Gerstmann-Straussler-Scheinker disease (Indiana and Swedish kindreds) express only PrP peptides encoded by the mutant allele
57. Effectiveness of anthracycline against experimental prion disease in syrian hamsters
58. A unified theory of prion propagation
59. A new variant of Creutzfeldt-Jakob disease in the UK
60. PrP deposition, microglial activation and neuronal apoptosis in murine scrapie
61. A proton nuclear magnetic resonance study of the site of metal binding in tetracycline
62. Sequence-specific resonance assignments in proteins
63. Amphotericin B treatment dissociates in vivo replication of the scrapie agent from PrP accumulation
64. Characterization of ineterleukin-1 production by microglia in colture